0001683168-22-006851.txt : 20221012 0001683168-22-006851.hdr.sgml : 20221012 20221012170340 ACCESSION NUMBER: 0001683168-22-006851 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221003 FILED AS OF DATE: 20221012 DATE AS OF CHANGE: 20221012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Chad Norman CENTRAL INDEX KEY: 0001949607 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33216 FILM NUMBER: 221307354 MAIL ADDRESS: STREET 1: 645 MOLLY LANE, SUITE 150 CITY: WOODSTOCK STATE: GA ZIP: 30189 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001367083 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680423298 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 645 MOLLY LANE, SUITE 150 CITY: WOODSTOCK STATE: GA ZIP: 30189 BUSINESS PHONE: 800-759-9305 MAIL ADDRESS: STREET 1: 645 MOLLY LANE, SUITE 150 CITY: WOODSTOCK STATE: GA ZIP: 30189 FORMER COMPANY: FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc. DATE OF NAME CHANGE: 20060622 3 1 ownership.xml X0206 3 2022-10-03 0 0001367083 Sonoma Pharmaceuticals, Inc. SNOA 0001949607 White Chad Norman C/O SONOMA PHARMACEUTICALS, INC. 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 0 1 0 0 Interim CFO Stock Option (right to buy) 2.21 2032-10-03 Common Stock 5000 D The Issuer granted the options as an initial grant upon Mr. White's appointment as interim Chief Financial Officer of the Issuer. The options vest in three equal tranches annually on the grant date anniversary, beginning on October 3, 2023 and becoming fully vested on October 3, 2025, or upon change of control of the Issuer. /s/ Chad N. White 2022-10-12